bm 13505 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 15 (68.18) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babycos, CR; Hood, JS; Ibrahim, IN; Kadowitz, PJ; McMahon, TJ; Nossaman, BD | 1 |
| Dellweg, H; Gross, R; Perzborn, E; Theis, JG | 1 |
| Allen, GT; Ogletree, ML | 1 |
| Hartig, F; Metz, J; Pill, J; Stegmeier, K | 1 |
| Higo, K; Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Karasawa, A; Kubo, K; Shirakura, S | 1 |
| Fairbairn, CE; Goodrum, DD; Krauss, AH; Ralston, TL; Williams, LS; Woodward, DF | 1 |
| Higo, K; Karasawa, A; Kawakage, M; Kubo, K; Obase, H; Ohshima, E; Shirakura, S | 1 |
| Dyson, MC; Kadowitz, PJ | 1 |
| Arner, M; Högestätt, ED; Uski, TK | 1 |
| DiMartino, MJ; Egan, JW; Griswold, DE; Hillegass, LM; Smith, EF | 1 |
| Sjöberg, T; Steen, S | 1 |
| Earl, CQ; Egan, JW; Griswold, DE; Hillegass, LM; Marshall, PJ; Smith, EF | 1 |
| Brezinski, ME; Lefer, AM; Smith, JA; Yanagisawa, A | 1 |
| Jugus, M; Kinter, LB; Smith, EF | 1 |
| McDonald, J; Smith, EF | 1 |
| Bertolino, F; Bessac, AM; Colpaert, FC; Delhon, A; Grelac, F; Lévy-Toledano, S; Maclouf, J; Maffre, M; Patoiseau, JF; Valentin, JP | 1 |
| Kromer, BM; Tippins, JR | 1 |
| Bertolino, F; Colpaert, FC; John, GW; Patoiseau, JF; Rieu, JP; Valentin, JP | 1 |
| Fukuda, Y; Fukuta, Y; Higashino, R; Ito, S; Kurimoto, T; Nomura, Y; Sato, R; Takei, M; Tamaki, H; Tanaka, T | 1 |
| Bernheim, J; Green, J; Mandelbaum, A; Podjarny, E; Rathaus, M | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
22 other study(ies) available for bm 13505 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Blood Pressure; Cats; Endothelins; Female; Male; Phenylacetates; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Sulfonamides; Thromboxane A2; Vasoconstrictor Agents | 1992 |
pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Carbazoles; Cell Membrane; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Ligands; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxanes; Vasoconstrictor Agents | 1992 |
Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Antagonism; Fatty Acids, Unsaturated; Heptanoic Acids; Hydrazines; Indoles; Male; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Species Specificity; Sulfonamides; Thromboxane A2 | 1992 |
Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cholesterol Esters; Coronary Artery Disease; Diet, Atherogenic; In Vitro Techniques; Lipid Metabolism; Male; Microsomes; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Sterol O-Acyltransferase; Sulfonamides; Thromboxanes; Vasoconstrictor Agents | 1992 |
Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzimidazoles; Benzoxepins; Blood Pressure; Cats; Dogs; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Sulfonamides; Thromboxane A2 | 1991 |
Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aspirin; Benzimidazoles; Benzoxepins; Blood Pressure; Death, Sudden; Dose-Response Relationship, Drug; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation Inhibitors; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane A2; Thromboxanes; Ticlopidine | 1991 |
Ca2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Dinoprost; Dose-Response Relationship, Drug; Fibroblasts; Hydantoins; Mice; Phenylacetates; Platelet-Derived Growth Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins F, Synthetic; Receptors, Prostaglandin; Sulfonamides | 1991 |
Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Adult; Animals; Benzimidazoles; Benzoxepins; Cats; Dogs; Drug Interactions; Epinephrine; Guinea Pigs; Humans; In Vitro Techniques; Mice; Middle Aged; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1991 |
Influence of SK&F 96148 on thromboxane-mediated responses in the airways of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Cats; Endothelins; Endotoxins; Escherichia coli; Female; Male; Phenylacetates; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Respiratory Physiological Phenomena; Respiratory System; Sulfonamides; Thromboxane A2; Thromboxanes | 1991 |
Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Alprostadil; Biphenyl Compounds; Dinoprost; Dinoprostone; Female; Hand; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Sulfonamides; Thromboxanes; Veins | 1991 |
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes | 1989 |
The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Aged; Female; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Vascular Resistance | 1989 |
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Disease; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1989 |
Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Cats; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium; In Vitro Techniques; Male; Methylene Blue; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Superoxides; Thromboxanes; Vasodilation | 1987 |
Effect of the thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Endotoxins; Heart Rate; Leukocyte Count; Male; Phenylacetates; Platelet Count; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Salmonella enteritidis; Shock, Septic; Sulfonamides; Thromboxanes | 1988 |
Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Arrhythmia Agents; Death, Sudden; Dose-Response Relationship, Drug; Electrocardiography; Male; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Respiration; Sulfonamides; Thromboxanes | 1988 |
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hematocrit; Humans; Hydrazines; In Vitro Techniques; Male; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Sulfonamides; Thromboxane A2; Thromboxanes | 1995 |
Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cattle; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Sheep; Sulfonamides; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Hydrazines; Hypertension, Pulmonary; Male; Phenylacetates; Rats; Receptors, Thromboxane; Sulfonamides; Thromboxane A2 | 1997 |
Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Cilostazol; Drug Interactions; Fibrinolytic Agents; Guinea Pigs; Heptanoic Acids; Humans; Indans; Male; Mice; Mice, Inbred ICR; Phenylacetates; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Receptors, Thromboxane; Sulfonamides; Tetrazoles; Vasoconstrictor Agents | 1998 |
Role of thromboxane in the altered vascular reactivity of pregnant rats with adriamycin nephropathy.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Dose-Response Relationship, Drug; Doxorubicin; Female; In Vitro Techniques; Kidney Diseases; Mesenteric Arteries; Norepinephrine; Phenylacetates; Pregnancy; Pregnancy Complications; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxanes; Vascular Resistance; Vasoconstrictor Agents | 1999 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |